David Keren

David Keren has a diverse work experience history. David started their career as a Medical Director at Warde Medical Laboratory in 1989 and held this role until 2011. In 1996, they also served on the DIRC committee at CAP until 2001. Moving forward, David became a Trustee at the American Board of Pathology from 2005 to 2013. In 2003, they became a Board Member at Ozone House and remained in that position until 2013 as well. In 2013, David transitioned to the University of Michigan Medical School as the Director of the Division of Clinical Pathology Laboratories, and held this role until 2018. Currently, David is the Chief Executive Officer of InheRET, Inc. which they started in 2018.

David Keren holds a MD degree from the University of Illinois College of Medicine. The specific dates of their education are not mentioned.